Related Experiment Videos

Introducing the Tehran Heart Center's Premature Coronary Atherosclerosis Cohort: THC-PAC Study

Seyed Hesameddin Abbasi1, Seyed Ebrahim Kassaian1, Saeed Sadeghian1

  • 1Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Younger patients with coronary artery disease (CAD) exhibit numerous risk factors, increasing their likelihood of major adverse cardiac events (MACE). This study highlights the prevalence of these factors in a Middle Eastern cohort.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Limited data exists on premature coronary artery disease (CAD).
  • The Tehran Heart Center's Premature Coronary Atherosclerosis Cohort Study (THC-PAC) is the first in the Middle East to investigate major adverse cardiac events (MACE) in young CAD patients.

Purpose of the Study:

  • To assess MACE in young patients with premature CAD.
  • To identify risk factors associated with MACE in this demographic.

Main Methods:

  • A cohort of 1232 premature CAD patients (males ≤ 45, females ≤ 55) residing in Tehran underwent coronary angiography between 2004-2011.
  • A 10-year follow-up initiated in 2012, with annual clinical visits or telephone calls.
  • MACE endpoint included death, myocardial infarction, stroke, new coronary revascularization (PCI/CABG), or new coronary involvement.

Main Results:

  • The cohort (mean age 45.1 years) showed high frequencies of hyperlipidemia (71.8%), hypertension (46.7%), positive family history (43.8%), smoking (38.8%), and diabetes (31.7%).
  • Mean BMI was high (29.2 kg/m²), with 43.3% overweight and 35.8% obese.
  • Females had higher BMI and abdominal circumference compared to males (P < 0.001 and P = 0.035, respectively).
  • Successful follow-up was achieved in 95.2% of patients with a median duration of 55.3 months.

Conclusions:

  • Younger CAD patients present with a high burden of conventional risk factors.
  • These risk factors may predispose them to a higher incidence of recurrent MACE compared to the general population or older CAD patients.
Abstract

Related Concept Videos